Form D · Pharmaceuticals

RQx Pharmaceuticals, Inc.

La Jolla, CA · CIK 0001507544

Offering snapshot reported Feb 17, 2011 · SEC filing

Reported sold
$1.19M
Offering amount: $7M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 1, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$596K$1.19MDec 10, 2010: $1,025,000.00Dec 10, 2010Feb 17, 2011: $1,191,716.00Feb 17, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,025,000 → $1,191,716
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 17, 2011Amendment$1,191,716$166,716vs Dec 10, 20103SEC filing
Dec 10, 2010Initial$1,025,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-151693

Source: Form D, filed Feb 17, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas A. Coll Executive
Douglas Downs Executive
Jay Litcher Director
Floyd Romesberg Director
Court R. Turner Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
11099 N. Torrey Pines Road Suite 290
La Jolla, CA, 92037